Biotech and venture funding
Everything filed under system in our medical research coverage, the 6 reports filed on it so far.
Caribou Biosciences discontinues CAR-T therapies, cuts staff
Caribou Biosciences is halting development of two off-the-shelf CAR-T cancer therapies, including its Phase 3-ready candidate vispa-cel, and laying...
Forbion Raises Record $2.6 Billion for Life Sciences Funds
Forbion has secured $2.6 billion across two new venture funds.
Shionogi Acquires IntraBio for $2 Billion to Expand Rare Disease Portfolio
Shionogi has agreed to acquire biotech firm IntraBio for $2 billion in cash, gaining the marketed rare disease therapy Aqneursa.
Kura spins out Caspian to test menin inhibitors for diabetes
Kura Oncology has spun out a new biotech startup, Caspian Therapeutics, to develop menin inhibitor drugs for diabetes and cardiometabolic diseases.
Moonwalk Biosciences pivots to RNAi obesity drugs with $70M
Moonwalk Biosciences has raised $70 million in Series B funding to advance a pipeline of RNA interference drugs for obesity.
Invivyd chairman Marc Elia becomes CEO
Infectious disease biotech Invivyd has appointed board chairman Marc Elia as its new CEO.